2018-12-28 · Notice · 2018-28213
Product-Specific Guidance for Linaclotide; Draft Guidance for Industry; Availability
Linaclotide
Open attributed record →Federal Register publication year
2018 FDA Federal Register peptide records
7 documents attributed to FDA and HHS and published in 2018, connected only through exact reviewed peptide-name matches.
2018-12-26 · Notice · 2018-27805
Determination of Regulatory Review Period for Purposes of Patent Extension; ADLYXIN
Lixisenatide
Open attributed record →2018-12-04 · Notice · 2018-26289
Determination of Regulatory Review Period for Purposes of Patent Extension; TRULANCE
Plecanatide
Open attributed record →2018-11-29 · Notice · 2018-25950
Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability
Plecanatide
Open attributed record →2018-10-22 · Notice · 2018-22956
Determination of Regulatory Review Period for Purposes of Patent Extension; TYMLOS
Abaloparatide
Open attributed record →2018-04-10 · Notice · 2018-07256
Notice of Approval of Products Under Voucher: Rare Pediatric Disease Priority Review Vouchers
Lixisenatide
Open attributed record →2018-02-09 · Notice · 2018-02667
Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability
Leuprolide
Open attributed record →